RibOSE - Glucose and Resistance Exercise Training
RibOSE
RibOSE - Effects of Glucose Ingestion During Resistance Exercise Training on Ribosomal Biogenesis in Skeletal Muscle
1 other identifier
interventional
16
1 country
1
Brief Summary
The aim of the study is to investigate the effects of ingesting glucose during five bouts of resistance exercise on muscle biological charateristics in m. vastus lateralis of moderately trained healthy individuals (20-45 years of age, n=20)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Sep 2020
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedFirst Posted
Study publicly available on registry
September 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2020
CompletedFebruary 4, 2021
February 1, 2021
4 months
August 24, 2020
February 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total RNA in muscle tissue
Total RNA content in m. vastus lateralis (ug per mg tissue)
Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Secondary Outcomes (14)
Ribosomal RNA in skeletal muscle
Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Protein in skeletal muscle
Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Gene expression in skeletal muscle
Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Muscle fractional synthesis rate
Immediately after the intervention
Glucose in blood, after glucose/placebo intake
Immediately before glucose/placebo intake and 30 min, 45 min, 60 min and 195 min after initial glucose/placebo intake
- +9 more secondary outcomes
Other Outcomes (7)
Training diary
During each training session of the intervention
Body mass composition
Prior to the intervention
Dietary registration
During each day of the intervention
- +4 more other outcomes
Study Arms (2)
Glucose
ACTIVE COMPARATORGlucose will be ingested at three time points during resistance training (RT): 30 min prior to RT (30 g glucose mixed with 300 ml sugar-free Fun light lemonade), immediately prior to RT (30 g, 300 ml), and immediately after completion of training (30 g, 300 ml). Protein supplement will be ingested at two time points: 2 hours prior to RT (e.g. at 0700 hrs, 25 g) and immediately after completion of training (25 g). Placebo will be ingested during the afternoon (i.e. not during training; between 1800 hrs and 1900 hrs): 3 x 100 mg Stevia powder mixed with 3 x 300 ml sugar-free Fun light lemonade. (The dietary intervention spans from 2200 hrs on the evening prior to RT sessions to \~2.5 hrs after completion of RT. During this time frame, participants will ingest glucose and protein supplements only)
Placebo
PLACEBO COMPARATORPlacebo will be ingested at three time points during resistance training (RT): 30 min prior to RT (100 mg Stevia powder mixed with 300 ml sugar-free Fun light lemonade), immediately prior to RT (100 mg, 300 ml), and immediately after completion of training (100 mg, 300 ml). Protein supplement will be ingested at two time points: 2 hours prior to RT (e.g. at 0700 hrs, 25 g) and immediately after completion of training (25 g). Glucose will be ingested during the afternoon (i.e. not during training; between 1800 hrs and 1900 hrs): 3 x 30 g glucose mixed with 3 x 300 ml sugar-free Fun light lemonade. (The dietary intervention spans from 2200 hrs on the evening prior to RT sessions to \~2.5 hrs after completion of RT. I.e.: during this period, participants will ingest placebo and protein supplements only)
Interventions
To investigate the effects of glucose intake during resistance training on muscle biological adaptations
Eligibility Criteria
You may qualify if:
- Non-smoking
- Moderately trained (i.e. having performed 2-8 resistance training sessions per 14 days for the last six months)
You may not qualify if:
- Not able to understand Norwegian
- Unstable cardiovascular disease
- Illness or injury contradicting heavy strength training
- Disabling musculoskeletal disease
- Serious mental illness
- Allergy to local anaesthesia
- Impaired glucose tolerance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inland Norway University of Applied Sciences
Lillehammer, Norway
Related Publications (1)
Hammarstrom D, Ofsteng S, Koll L, Hanestadhaugen M, Hollan I, Apro W, Whist JE, Blomstrand E, Ronnestad BR, Ellefsen S. Benefits of higher resistance-training volume are related to ribosome biogenesis. J Physiol. 2020 Feb;598(3):543-565. doi: 10.1113/JP278455. Epub 2020 Jan 15.
PMID: 31813190BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stian Ellefsen, PhD
Inland Norway University of Applied Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- On each intervention day, participants will receive boluses of supplements in accordance with his or her study ID number. The list that links this ID number to the randomization code will be kept with the person who generated the randomization code (and stored on a safe server) until completion of data sampling and cleaning of data on main outcome measures. The person resonsible for generating the randomization code will not be involved in any aspects of data sampling or handling. None of the project collaborators/participants will have access to this list during the intervention or during data handling. Half the participants (n=10) will commence the intervention with GLU on Day 1, while the other half will commence with PLAC (randomized). For participants starting with GLU, half will perform training on their dominant leg, while the other half will perform training on their non-dominant leg. The same will be the case for participants starting with PLAC.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Administrator
Study Record Dates
First Submitted
August 24, 2020
First Posted
September 10, 2020
Study Start
September 1, 2020
Primary Completion
December 20, 2020
Study Completion
December 20, 2020
Last Updated
February 4, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share